Universität zu Köln

Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC (2020) Sydor S, Best J, Messerschmidt I, Manka P, Vilchez-Vargas R, Brodesser S, Lucas C, et al. Journal article Stabilization of Perivascular Mast Cells by Endothelial CNP (C-Type Natriuretic Peptide) (2020) Chen W, Werner F, Illerhaus A, Knopp T, Voelker K, Potapenko T, Hofmann U, et al. Journal article Cultural taxonomies in the Paleolithic-Old questions, novel perspectives (2020) Riede F, Araujo AGM, Barton MC, Bergsvik KA, Groucutt HS, Hussain ST, Fernandez-Lopez De Pablo J, et al. Journal article Correlation of skin rash and overall survival in patients with pancreatic cancer treated with gemcitabine and erlotinib-results from a non-interventional multi-center study (2020) Westphalen CB, Kukiolka T, Garlipp B, Hahn L, Fuchs M, Malfertheiner P, Reiser M, et al. Journal article Shared genetic etiology of obesity-related traits and Barrett's esophagus/adenocarcinoma: Insights from genome-wide association studies (2020) Bohmer AC, Hecker J, Schroder J, Gharahkhani P, May A, Gerges C, Anders M, et al. Journal article Last Neanderthal occupations at Central Iberia: the lithic industry of Jarama VI rock shelter (Valdesotos, Guadalajara, Spain) (2020) Ruiz MN, Jordá Pardo JF, Burow C, Kehl M, Pastoors A, Weniger GC, Wood R Journal article Role of Endogenous Regulators of Hem- And Lymphangiogenesis in Corneal Transplantation (2020) Clahsen T, Büttner C, Hatami N, Reis A, Cursiefen C Journal article, Review article A Randomized, Double-Blind, Phase III Trial of Neoadjuvant Chemotherapy (NACT) with atezolizumab/Placebo in Patients with Triple-Negative Breast Cancer (TNBC) Followed by Adjuvant Continuation of atezolizumab/Placebo (Gepardouze) (2020) Loibl S, Jackisch C, Seiler S, Rastogi P, Huober L, Denkert C, Schneeweiss A, et al. Conference contribution Serio - Side Effect Registry in Immuno-Oncology (2020) Koutzamanidis R, Mentzer D, Knauss S, Broeckelmann PJ, Hassel JC, Ugurel-Becker S, Pavel ME, et al. Conference contribution Germline Mutation Status and Therapy Response in High-Risk Early-Stage Breast Cancer: a Secondary Analysis of the Geparocto Randomized Clinical Trial (NCT02125344) (2020) Pohl-Rescigno E, Hauke J, Rhiem K, Moebus V, Furlanetto J, Denkert C, Fasching P, et al. Conference contribution